Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Birgitte
Birgitte Andersen, Bagsvaerd DK
| Patent application number | Description | Published |
|---|---|---|
| 20100016230 | Treatment Of Inflammatory Bowel Diseases With Mammal Beta Defensins - The present invention relates to treatment of inflammatory bowel diseases with mammal beta defensins. | 01-21-2010 |
| 20100016231 | Treatment Of Rheumatoid Arthritis With Mammal Beta Defensins - The present invention relates to treatment of rheumatoid arthritis with mammal beta defensins. | 01-21-2010 |
| 20100016232 | Treatment Of Inflammatory Diseases With Mammal Beta Defensins - The present invention relates to suppression of TNF-alpha activity with mammal beta defensins, which has utility in the treatment of pathological conditions associated with tumor necrosis factor alpha. | 01-21-2010 |
| 20110251139 | TREATMENT OF INFLAMMATORY BOWEL DISEASES WITH MAMMAL BETA DEFENSINS - The present invention relates to treatment of inflammatory bowel diseases with mammal beta defensins. | 10-13-2011 |
Birgitte Bang-Madsen, Norre Snede DK
| Patent application number | Description | Published |
|---|---|---|
| 20110064783 | Flavor Impregnation Of A Chewing Gum Core - A method of adding flavor to a chewing gum core of a chewing gum, the chewing gum including active pharmaceutical ingredients, the method of adding flavor to a chewing gum core including the steps of: providing a chewing gum core including gum base, impregnating the chewing gum core by adding at least one dose of liquid flavor mixture onto the chewing gum core prior to any optional coating of the chewing gum core, wherein at least the flavor in the liquid flavor mixture has affinity for the gum base in the chewing gum core. | 03-17-2011 |
Birgitte Nauntofte, Charlottenlund DK
| Patent application number | Description | Published |
|---|---|---|
| 20090169488 | Acidic solid oral compositons without erosive potential in saliva and method for determining erosive potential in saliva - Acidic oral compositions having calcium contents and effective pH-values in the area indicated by grey tone in FIG. | 07-02-2009 |
Birgitte Nielsen, Oslo NO
| Patent application number | Description | Published |
|---|---|---|
| 20110274336 | OPTIMIZING THE INITIALIZATION AND CONVERGENCE OF ACTIVE CONTOURS FOR SEGMENTATION OF CELL NUCLEI IN HISTOLOGICAL SECTIONS - A computer-implemented segmentation method is used to process an image representing a plurality of nuclei. The method is implemented in a computer having a processor and a physical memory. A set of instructions are provided to the processor the physical memory of the computer. The processor is configured by executing the set of instructions in the physical memory so as to automatically segment the image by: thresholding a grey-scale image to create a black and white image; identifying objects in the black and white image and removing objects failing to meet predetermined criteria; extracting objects; and applying an edge detector on the segmented image to identify the edges of the nuclei. Overlapping nuclei are split to improve results. | 11-10-2011 |
Birgitte Rönnow, Copenhagen K DK
| Patent application number | Description | Published |
|---|---|---|
| 20110099892 | MICROORGANISM EXPRESSING ALDOSE-1-EPIMERASE - A transformed microorganism capable of converting an aldopentose to a ketopentose at a higher rate than the equivalent microorganism prior to transformation. | 05-05-2011 |
Birgitte Rönnow, Copenhagen K DK
| Patent application number | Description | Published |
|---|---|---|
| 20110099892 | MICROORGANISM EXPRESSING ALDOSE-1-EPIMERASE - A transformed microorganism capable of converting an aldopentose to a ketopentose at a higher rate than the equivalent microorganism prior to transformation. | 05-05-2011 |
Birgitte Rönnow, Copenhagenk DK
| Patent application number | Description | Published |
|---|---|---|
| 20110244525 | MICROORGANISM EXPRESSING XYLOSE ISOMERASE - The present invention relates to a transformed microorganism capable of (a) a higher xylose isomerase activity than the equivalent microorganism prior to transformation; and/or (b) a higher growth rate in or on a growth medium comprising xylose than the equivalent microorganism prior to transformation; and/or (c) a faster metabolism of xylose than the equivalent microorganism prior to transformation; and/or (d) a higher production of ethanol when grown anaerobically on xylose as the carbon source than the equivalent microorganism prior to transformation. | 10-06-2011 |
Birgitte Skadhauge, Birkerod DK
| Patent application number | Description | Published |
|---|---|---|
| 20090029000 | Barley for Production of Flavor-Stable Beverage - According to the invention, there is provided null-LOX-1 barley and plant products produced thereof, such as malt manufactured by using barley kernels defective in synthesis of the fatty acid-converting enzyme lipoxygenase-1. Said enzyme accounts for the principal activity related to conversion of linoleic acid into 9-hydroperoxy octadecadienoic acid, a lipoxygenase pathway metabolite, which-through further enzymatic or spontaneous reactions may lead to the appearance of trans-2-nonenal. The invention enables brewers to produce a beer devoid of detectable trans-2-nonenal-specific off flavors, even after prolonged storage of the beverage. | 01-29-2009 |
| 20110195151 | BARLEY FOR PRODUCTION OF FLAVOR-STABLE BEVERAGE - According to the invention, there is provided null-LOX-1 barley and plant products produced thereof, such as malt manufactured by using barley kernels defective in synthesis of the fatty acid-converting enzyme lipoxygenase-1. Said enzyme accounts for the principal activity related to conversion of linoleic acid into 9-hydroperoxy octadecadienoic acid, a lipoxygenase pathway metabolite, which-through further enzymatic or spontaneous reactions-may lead to the appearance of trans-2-nonenal. The invention enables brewers to produce a beer devoid of detectable trans-2-nonenal-specific off flavors, even after prolonged storage of the beverage. | 08-11-2011 |
Birgitte Stuer-Lauridsen, Virum DK
| Patent application number | Description | Published |
|---|---|---|
| 20080317903 | Bacteriophage Resistant Lactic Acid Bacteria - A lactic acid bacterium (LAB) wherein an YjaE protein is essentially inactive and the LAB thereby get improved resistance to bacteriophages, a starter culture composition comprising the lactic acid bacterium and use of this starter culture manufacturing a food or feed product. | 12-25-2008 |
| 20110223251 | BACTERIAL COMPOSITION - The present invention relates to a bacterial composition which has a long shelf-life, and a process for producing such compositions. The invention further relates to food products comprising the bacterial composition. | 09-15-2011 |
Birgitte Urs, Copenhagen DK
| Patent application number | Description | Published |
|---|---|---|
| 20080305986 | Multimers of Peptides - Described are compounds useful for trimerising chemical entities, methods of trimerising chemical entities, and trimerised entities. In one aspect, the entities are peptides. | 12-11-2008 |
Birgitte Ursø, Copenhagen O DK
| Patent application number | Description | Published |
|---|---|---|
| 20100056764 | Antibodies against human NKG2D and uses thereof - The present invention provides isolated anti-human NKG2D monoclonal antibodies useful for therapeutic applications in humans. Typically, the antibodies are fully human or humanized to minimize the risk for immune responses against the antibodies when administered to a patient. Preferred antibodies include human monoclonal antibodies MS and 21F2. As described herein, other antigen-binding molecules such as, e.g., antigen-binding antibody fragments, antibody derivatives, and multi-specific molecules, can be designed or derived from such antibodies. | 03-04-2010 |
Birgitte Willumsen, Bronshoj DK
| Patent application number | Description | Published |
|---|---|---|
| 20090306092 | METHOD FOR TREATING COGNITIVE DEFICITS - The invention relates to methods of treating cognitive dysfunction and improving cognitive functioning comprising the administration of trans-4-((1R,3S)-6-chloro-3-phenylindan- | 12-10-2009 |
| 20110178094 | Oral Formulation - The invention relates to a pharmaceutical composition intended for oral administration comprising low doses of 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and to a composition comprising the compound. | 07-21-2011 |
| 20110207744 | Method for treating cognitive deficits - The invention relates to methods of treating cognitive dysfunction and improving cognitive functioning comprising the administration of trans-4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine or a pharmaceutically acceptable salt thereof to a patient in need thereof. Moreover the invention relates to an improved binder in a composition comprising 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine. | 08-25-2011 |
Birgitte Wintherlund, Bagsvaerd DK
| Patent application number | Description | Published |
|---|---|---|
| 20090131510 | COMPOUNDS WITH ACTIVITY AT ESTROGEN RECEPTORS - Disclosed herein are compounds of Formula I | 05-21-2009 |
Birgitte Winther Lund, Bagsvaerd DK
| Patent application number | Description | Published |
|---|---|---|
| 20090270449 | AMINOPHENYL DERIVATIVES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS - Disclosed herein is a novel class of aminophenyl compounds having the structure: | 10-29-2009 |
| 20110046237 | COMPOUNDS WITH ACTIVITY AT ESTROGEN RECEPTORS - Disclosed herein are methods of treatment and prevention of diseases and disorders related to estrogen receptors comprising administering novel di-aromatic compounds to patients in need thereof. | 02-24-2011 |